Artificial heart maker to cut 21 jobs, outsource manufacturing

JAN. 15–DANVERS, Mass.– Abiomed Inc., the company that makes the first self-contained artificial heart, is laying off 21 workers and plans to outsource most of its manufacturing of electronic components to cut costs.

”The challenges ahead are changing, and our resource requirements are evolving,” David Lederman, chief executive, told The Associated Press.

Abiomed manufacturers and sells a heart pump but has gained worldwide attention for its trial of the AbioCor, a self-contained, implantable replacement heart.

The device was implanted in an eighth recipient last week after a nine-month hiatus, during which shares of the company sagged.

Of the first seven recipients, only one remains alive but the company emphasizes the device is intended only to extend the lives of critically ill patients expected to live 30 days or less, and says it is pleased with the device’s performance.

Last month, Chief Financial Officer John Thero stepped down from the company to pursue a ”venture-backed” opportunity.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.